1. Home
  2. AOSL vs CGEM Comparison

AOSL vs CGEM Comparison

Compare AOSL & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOSL
  • CGEM
  • Stock Information
  • Founded
  • AOSL 2000
  • CGEM 2016
  • Country
  • AOSL United States
  • CGEM United States
  • Employees
  • AOSL N/A
  • CGEM N/A
  • Industry
  • AOSL Semiconductors
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AOSL Technology
  • CGEM Health Care
  • Exchange
  • AOSL Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • AOSL 616.9M
  • CGEM 530.0M
  • IPO Year
  • AOSL 2010
  • CGEM 2021
  • Fundamental
  • Price
  • AOSL $24.12
  • CGEM $7.67
  • Analyst Decision
  • AOSL Buy
  • CGEM Strong Buy
  • Analyst Count
  • AOSL 3
  • CGEM 5
  • Target Price
  • AOSL $32.33
  • CGEM $30.00
  • AVG Volume (30 Days)
  • AOSL 371.0K
  • CGEM 324.5K
  • Earning Date
  • AOSL 08-06-2025
  • CGEM 08-07-2025
  • Dividend Yield
  • AOSL N/A
  • CGEM N/A
  • EPS Growth
  • AOSL N/A
  • CGEM N/A
  • EPS
  • AOSL N/A
  • CGEM N/A
  • Revenue
  • AOSL $680,974,000.00
  • CGEM N/A
  • Revenue This Year
  • AOSL $7.05
  • CGEM N/A
  • Revenue Next Year
  • AOSL $2.54
  • CGEM N/A
  • P/E Ratio
  • AOSL N/A
  • CGEM N/A
  • Revenue Growth
  • AOSL 3.57
  • CGEM N/A
  • 52 Week Low
  • AOSL $15.90
  • CGEM $6.85
  • 52 Week High
  • AOSL $53.29
  • CGEM $21.01
  • Technical
  • Relative Strength Index (RSI)
  • AOSL 56.36
  • CGEM 38.41
  • Support Level
  • AOSL $22.79
  • CGEM $8.47
  • Resistance Level
  • AOSL $24.87
  • CGEM $9.25
  • Average True Range (ATR)
  • AOSL 1.20
  • CGEM 0.45
  • MACD
  • AOSL 0.05
  • CGEM -0.12
  • Stochastic Oscillator
  • AOSL 70.18
  • CGEM 5.06

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: